N3 acted as a “chemo-receptor” binding to cancer cell surface glycoprotein, allowing the ICB aptamer to covalently bind on the cancer cell surface for a long time without detachment and internalization, improving the efficiency and accuracy of cancer therapy by blocking the PD1-PDL1 signaling pathway. This evidence concerns the gene CD274 and cancer.